White House to launch TrumpRx website for drug purchases, Pfizer to lower prices

The White House is set to launch a direct-to-consumer website for Americans to purchase medications, named TrumpRx. This announcement comes alongside news that Pfizer plans to reduce prices on several of its drugs in the United States, according to sources familiar with the situation, as reported by the Wall Street Journal.

The initiative aims to provide Americans with easier access to pharmaceuticals at potentially lower costs. The specifics regarding the launch date of the TrumpRx website and the details of the price reductions from Pfizer have not yet been disclosed.

This development follows ongoing discussions about drug pricing and accessibility in the U.S. market. For more on related coverage, see recent developments in healthcare policy.

Further updates are expected as the White House prepares to unveil these initiatives.